Previous studies observed the amplification or over-expression of the c-Myc gene in gastric cancer [35], breast cancer [36], cervical cancer [37], and other cancers, suggesting that the abnormal activation of the c-Myc gene is closely related to the occurrence and development of malignant tumors [38,39]. This evidence concerns the gene MYC and cervical cancer.